TREANDA

This brand name is authorized in United States. It is also authorized in Canada, Hong Kong SAR China.

Active ingredients

The drug TREANDA contains one active pharmaceutical ingredient (API):

1	Bendamustine UNII 981Y8SX18M - BENDAMUSTINE HYDROCHLORIDE
	Bendamustine is an alkylating antitumour agent with unique activity. The antineoplastic and cytocidal effect of bendamustine is based essentially on a cross-linking of DNA single and double strands by alkylation. As a result, DNA matrix functions and DNA synthesis and repair are impaired.
	Read more about Bendamustine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TREANDA Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AA09	Bendamustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02392550, 02392569
HK	Department of Health Drug Office	59067, 62300
US	FDA, National Drug Code	63459-390, 63459-391